Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for ENL in Leprosy
NCT00406861Phase 2Unknown
- Sponsor
- The Leprosy Mission Bangladesh
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of montelukast in erythema nodosum leprosum (ENL) (3 arms), sponsored by The Leprosy Mission Bangladesh. Primary endpoints: Decrease in Erythema Nodosum Leprosum score at 24 weeks, Absence of new nerve function impairment at 24 weeks and 1 more. Status: unknown.
02
Drugs
montelukast
03
Conditions
erythema nodosum leprosum (ENL)
Beyond the preview
Go deeper on NCT00406861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406861.